Photo from wikipedia
Key Points The Khorana score did risk-stratify cancer patients according to 6-month risk of VTE, but only for some cancer types. Absolute risk estimates were lower than previously reported, questioning… Click to show full abstract
Key Points The Khorana score did risk-stratify cancer patients according to 6-month risk of VTE, but only for some cancer types. Absolute risk estimates were lower than previously reported, questioning the benefit of ambulatory thromboprophylaxis in cancer patients.
Keywords:
validation khorana;
venous thromboembolism;
predicting venous;
score predicting;
khorana score;
cancer
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!